| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| James R Lathrop, Sheldon N Rosen, Margaret M Heitkemper, Diana Taibi Buchana. Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome: The State of the Science. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates. 2023-04-19. PMID:37074964. |
a synopsis of the endocannabinoid system provides a basis for the hypothesis that a lack of cannabidiol in modern high-potency Δ9-tetrahydrocannabinol cannabis may be contributory to cannabis hyperemesis syndrome and possibly other cannabis use disorders. |
2023-04-19 |
2023-08-14 |
Not clear |
| Erica Wennberg, Sarah B Windle, Kristian B Filion, Brett D Thombs, Genevieve Gore, Andrea Benedetti, Roland Grad, Carolyn Ells, Mark J Eisenber. Roadside screening tests for cannabis use: A systematic review. Heliyon. vol 9. issue 4. 2023-04-17. PMID:37064483. |
we searched six databases (inception-march 2020) and grey literature sources for primary studies evaluating test characteristics of roadside screening tests for cannabis use compared to laboratory tests for cannabinoids in blood or oral fluid. |
2023-04-17 |
2023-08-14 |
Not clear |
| Basil N Nduma, Kelly A Mofor, Jason Tatang, Chukwuyem Ekhator, Solomon Ambe, Ekokobe Fonke. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. vol 15. issue 3. 2023-04-17. PMID:37065370. |
around the world, about 15 to 40% of individuals with inflammatory bowel disease (ibd) rely on cannabis and cannabinoids to reduce the need for other medications, as well as increase appetite and reduce pain. |
2023-04-17 |
2023-08-14 |
human |
| Basil N Nduma, Kelly A Mofor, Jason Tatang, Chukwuyem Ekhator, Solomon Ambe, Ekokobe Fonke. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. vol 15. issue 3. 2023-04-17. PMID:37065370. |
whereas more and more patients continue to report benefits accruing from cannabis and cannabinoid usage in ibd, agreement relative to the use of cannabis and its derivatives in ibd remains unclear. |
2023-04-17 |
2023-08-14 |
human |
| Basil N Nduma, Kelly A Mofor, Jason Tatang, Chukwuyem Ekhator, Solomon Ambe, Ekokobe Fonke. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. vol 15. issue 3. 2023-04-17. PMID:37065370. |
it is also notable that the findings were characterized by a state of high heterogeneity in terms of the study designs of the studies that were selected, disease activity indices, the duration of treatment by different scholarly researchers, the difference in the modes of administration of cannabinoid and cannabis by different researchers, variations in cannabis dosage, differences in the selected studies' inclusion criteria, and variations in their case definitions. |
2023-04-17 |
2023-08-14 |
human |
| Basil N Nduma, Kelly A Mofor, Jason Tatang, Chukwuyem Ekhator, Solomon Ambe, Ekokobe Fonke. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. vol 15. issue 3. 2023-04-17. PMID:37065370. |
in the future, it is recommended that randomized controlled trials center, set universal parameters for ibd treatment using cannabis and cannabinoids to determine intervention safety and effectiveness as well as having homogenous outcomes that can be compared between different studies. |
2023-04-17 |
2023-08-14 |
human |
| Ángela Suárez-Jacobo, Adrián Díaz Pacheco, Edgar Bonales-Alatorre, Gustavo Adolfo Castillo-Herrera, Jorge Alberto García-Fajard. Molecules (Basel, Switzerland). vol 28. issue 7. 2023-04-13. PMID:37049659. |
in this article, the phytochemical compounds (cannabinoids, terpenes, and phenolic compounds), the current status of legalization, extraction techniques, and research advances in cannabis in latin america are reviewed. |
2023-04-13 |
2023-08-14 |
Not clear |
| Jamie Cuchiaro, James Baumgartner, Melissa M Reynold. Modeling a pesticide remediation strategy for preparative liquid chromatography using high-performance liquid chromatography. Journal of cannabis research. vol 5. issue 1. 2023-04-13. PMID:37055853. |
cannabis sativa l. also known as industrial hemp, is primarily cultivated as source material for cannabinoids cannabidiol (cbd) and ∆9-tetrahydrocannabinol (∆9-thc). |
2023-04-13 |
2023-08-14 |
Not clear |
| Jamie Cuchiaro, James Baumgartner, Melissa M Reynold. Modeling a pesticide remediation strategy for preparative liquid chromatography using high-performance liquid chromatography. Journal of cannabis research. vol 5. issue 1. 2023-04-13. PMID:37055853. |
preparative liquid chromatography (plc) is an attractive strategy for remediating pesticide contaminants while also facilitating targeted isolation cannabinoids in cannabis biomass. |
2023-04-13 |
2023-08-14 |
Not clear |
| Ashley M Lambros, Kelly A Sagar, M Kathryn Dahlgren, Deniz Kosereisoglu, Celine El-Abboud, Rosemary T Smith, Staci A Grube. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure. Scientific reports. vol 13. issue 1. 2023-04-11. PMID:37041309. |
increasing numbers of individuals have access to cannabinoid-based products containing various amounts of delta-9-tetrahydrocannabinol (thc), cannabidiol (cbd), and other cannabinoids. |
2023-04-11 |
2023-08-14 |
Not clear |
| Ashley M Lambros, Kelly A Sagar, M Kathryn Dahlgren, Deniz Kosereisoglu, Celine El-Abboud, Rosemary T Smith, Staci A Grube. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure. Scientific reports. vol 13. issue 1. 2023-04-11. PMID:37041309. |
exposure to specific cannabinoids likely influences outcomes; however, current methods for quantifying cannabis exposure do not account for the cannabinoid concentrations of the products used. |
2023-04-11 |
2023-08-14 |
Not clear |
| Zamir K Punja, Darren B Sutton, Tommy Ki. Glandular trichome development, morphology, and maturation are influenced by plant age and genotype in high THC-containing cannabis (Cannabis sativa L.) inflorescences. Journal of cannabis research. vol 5. issue 1. 2023-04-04. PMID:37016398. |
glandular capitate trichomes which form on bract tissues of female inflorescences of high thc-containing cannabis sativa l. plants are important sources of terpenes and cannabinoids. |
2023-04-04 |
2023-08-14 |
Not clear |
| Xixi Wang, Tong Xu, Dongliu Luo, Shanshan Li, Xinyu Tang, Jiayi Ding, Hang Yin, Shu L. Cannabidiol Alleviates Perfluorooctanesulfonic Acid-Induced Cardiomyocyte Apoptosis by Maintaining Mitochondrial Dynamic Balance and Energy Metabolic Homeostasis. Journal of agricultural and food chemistry. 2023-04-03. PMID:37010249. |
cannabidiol (cbd) is a nonpsychoactive cannabinoid without potential adverse cardiotoxicity and has antioxidant and anti-inflammatory properties that reduce multiorgan damage and dysfunction. |
2023-04-03 |
2023-08-14 |
mouse |
| Rie Tanaka, Sakumi Mizutani, Maiko Kawamura, Hiroyuki Fuchino, Nobuo Kawahara, Ruri Kikura-Hanajir. [Determination of 11 Cannabinoids in Cannabis sativa L. by Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-Q-TOF-MS)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. vol 143. issue 4. 2023-04-02. PMID:37005243. |
[determination of 11 cannabinoids in cannabis sativa l. by liquid chromatography quadrupole time-of-flight mass spectrometry (lc-q-tof-ms)]. |
2023-04-02 |
2023-08-14 |
Not clear |
| Rie Tanaka, Sakumi Mizutani, Maiko Kawamura, Hiroyuki Fuchino, Nobuo Kawahara, Ruri Kikura-Hanajir. [Determination of 11 Cannabinoids in Cannabis sativa L. by Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-Q-TOF-MS)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. vol 143. issue 4. 2023-04-02. PMID:37005243. |
eleven major cannabinoids from each subdivided tissue of drug-type and fiber-type cannabis plants were determined by means of a liquid chromatography quadrupole time-of-flight mass spectrometry (lc-q-tof-ms). |
2023-04-02 |
2023-08-14 |
Not clear |
| Nitzan Halamish, Lihi Bar-Lev Schleider, Sydney McGuire, Victor Novac. Can we predict the treatment doses of THC and CBD and does it matter? European journal of internal medicine. 2023-04-01. PMID:37003923. |
medical cannabis is an increasingly prevalent treatment for a wide variety of indications, yet there is still no uniformly accepted protocol for the titration of cannabinoid doses. |
2023-04-01 |
2023-08-14 |
Not clear |
| Amy L Haycraf. Cannabis update: Anxiety disorders and post-traumatic stress disorder. Journal of the American Association of Nurse Practitioners. 2023-03-31. PMID:37000126. |
patients are increasingly inquiring about cannabis, and clinicians must educate themselves with reliable cannabinoid information for patient education. |
2023-03-31 |
2023-08-14 |
Not clear |
| Pravesh Sharma, Doug B Mathews, Quang Anh Nguyen, Gillian L Rossmann, Christi A Patten, Christopher J Hammon. Old Dog, New Tricks: A Review of Identifying and Addressing Youth Cannabis Vaping in the Pediatric Clinical Setting. Clinical medicine insights. Pediatrics. vol 17. 2023-03-30. PMID:36993933. |
cannabis vaping has emerged as a predominant mode of cannabis use among united states (us) adolescents and young adults (aya) primarily due to the popularity of modifiable designs of vaping devices coupled with changes in cannabis policies and increased availability of cannabinoid products. |
2023-03-30 |
2023-08-14 |
dog |
| Alexandra B Collins, Francesca L Beaudoin, Jane Metrik, Rachel S Wightma. "I still partly think this is bullshit": A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting. Drug and alcohol dependence. vol 246. 2023-03-30. PMID:36996524. |
"i still partly think this is bullshit": a qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting. |
2023-03-30 |
2023-08-14 |
Not clear |
| Alexandra B Collins, Francesca L Beaudoin, Jane Metrik, Rachel S Wightma. "I still partly think this is bullshit": A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting. Drug and alcohol dependence. vol 246. 2023-03-30. PMID:36996524. |
cannabinoid hyperemesis syndrome (chs) has been one concern related to increased cannabis use patterns. |
2023-03-30 |
2023-08-14 |
Not clear |